Cargando…
Gemcitabine-Containing Chemotherapy for the Treatment of Metastatic Myxofibrosarcoma Refractory to Doxorubicin: A Case Series
Background: Myxofibrosarcoma is a type of soft-tissue sarcoma that is associated with high rates of local recurrence and distant metastases. The first-line treatment for metastatic soft-tissue sarcoma has conventionally been doxorubicin-based. Recent evidence suggests that myxofibrosarcoma may be mo...
Autores principales: | Elkrief, Arielle, Kazandjian, Suzanne, Alcindor, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985763/ https://www.ncbi.nlm.nih.gov/pubmed/33562486 http://dx.doi.org/10.3390/curroncol28010078 |
Ejemplares similares
-
Pembrolizumab for Refractory Metastatic Myxofibrosarcoma: A Case Report
por: Song, Haa-Na, et al.
Publicado: (2018) -
Gemcitabine, Navelbine, and Doxorubicin as Treatment for Patients with Refractory or Relapsed T-Cell Lymphoma
por: Qian, Zhengzi, et al.
Publicado: (2015) -
Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcoma
por: Colia, Vittoria, et al.
Publicado: (2017) -
Gemcitabine in Bone Sarcoma Resistant to Doxorubicin-Based
Chemotherapy
por: Merimsky, Ofer, et al.
Publicado: (2000) -
Palliative Surgical Resection of an Extensive Metastatic Cardiac
Myxofibrosarcoma
por: Karangelis, Dimos, et al.
Publicado: (2019)